Evidence map›Paper›PMID 27241904›Full record

ArticleScientific reports2016

A highly soluble, non-phototoxic, non-fluorescent blebbistatin derivative.

Boglárka H Várkuti, Miklós Képiró, István Ádám Horváth, László Végner, Szilvia Ráti, Áron Zsigmond, György Hegyi, Zsolt Lenkei, Máté Varga, András Málnási-Csizmadia

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 127 citations in OpenAlex.

  1. A Beginner's Guide to Cardiac Optical Mapping.Cardiovascular engineering and technology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Swimming motions evoke Piezo1-dependent CaCurrent biology : CB · 2025
    Article
  11. Measurement of cellular traction forces during confined migration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. A combined experimental and computational analysis of mantATP turnover in skinned muscle fibers.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Boglárka H VárkutiDepartment of Biochemistry, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
Miklós KépiróDepartment of Biochemistry, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
István Ádám HorváthDepartment of Biochemistry, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
László VégnerDepartment of Biochemistry, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
Szilvia RátiDepartment of Biochemistry, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
Áron ZsigmondDepartment of Genetics, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
György HegyiDepartment of Biochemistry, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
Zsolt LenkeiBrain Plasticity Unit, ESPCI-Paris-Tech, CNRS UMR8249, Paris, France.
Máté VargaDepartment of Genetics, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
András Málnási-CsizmadiaDepartment of Biochemistry, Institute of Biology, Eötvös Loránd University, H-1117 Budapest, Hungary.
Eötvös Loránd University · HUCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blebbistatin is a commonly used molecular tool for the specific inhibition of various myosin II isoforms both in vitro and in vivo. Despite its popularity, the use of blebbistatin is hindered by its poor water-solubility (below 10 micromolar in aqueous buffer) and blue-light sensitivity, resulting in the photoconversion of the molecule, causing severe cellular phototoxicity in addition to its cytotoxicity. Furthermore, blebbistatin forms insoluble aggregates in water-based media above 10 micromolar with extremely high fluorescence and also high adherence to different types of surfaces, which biases its experimental usage. Here, we report a highly soluble (440 micromolar in aqueous buffer), non-fluorescent and photostable C15 amino-substituted derivative of blebbistatin, called para-aminoblebbistatin. Importantly, it is neither photo- nor cytotoxic, as demonstrated on HeLa cells and zebrafish embryos. Additionally, para-aminoblebbistatin bears similar myosin II inhibitory properties to blebbistatin or para-nitroblebbistatin (not to be confused with the C7 substituted nitroblebbistatin), tested on rabbit skeletal muscle myosin S1 and on M2 and HeLa cells. Due to its drastically improved solubility and photochemical feature, as well as lack of photo- or cytotoxicity, para-aminoblebbistatin may become a feasible replacement for blebbistatin, especially at applications when high concentrations of the inhibitor or blue light irradiation is required.

Indexed as

Dermatitis, PhototoxicFluorescenceAnimalsCell SurvivalChemical PrecipitationDrug StabilityHeLa CellsHeterocyclic Compounds, 4 or More RingsHumansMyosin Type IIRabbitsSolubilitySurvival AnalysisZebrafishblebbistatinHeterocyclic Compounds, 4 or More RingsMyosin Type II

Identifiers

PMID27241904
PMCPMC4886532
OpenAlexW2419337888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.